FilingReader Intelligence

JSE Limited executives accept restricted share grants

March 13, 2025 at 09:00 PM UTCBy FilingReader AI

JSE Limited (JSE:JSE) announced that executive directors, prescribed officers, and the company secretary have accepted allocations of restricted JSE ordinary shares granted through the JSE LTIS 2018 Trust. The Trust acquired a total of 794,296 JSE ordinary shares in the open market at a volume-weighted average price of R129.7689 per share. Key executive recipients include Leila Fourie (Group CEO) with 184,870 shares (R23,990,376), and Fatima Suliman (Group CFO) with 63,648 shares (R8,259,530). Other prescribed officers and the company secretary also received allocations. The shares are held on a direct beneficial basis and are restricted until vesting criteria are fulfilled, which include achieving corporate performance targets and continued employment with the JSE. Vesting will occur in two tranches, in March 2028 and March 2029. The allocations were approved by the JSE’s Group Remuneration Committee.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

JSE:JSEJohannesburg Stock Exchange

News Alerts

Get instant email alerts when JSE LIMITED publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →